A decision by the Centers for Disease Control and Prevention to shut down a Fort Detrick military lab may affect research underway there.
At the time of a cease and desist letter from the CDC, the U.S. Army Medical Research Institute of Infectious Diseases was working on a multi-year project to develop antibody-based therapies for four lethal viruses.
The project is led by the Albert Einstein College of Medicine, under the Montefiore Medical Center, and was awarded $22 million in April, according to a press release. Mapp Biopharmaceutical Inc., the University of Texas at Austin and Adimab LLC are also partners.
U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
The post Effect of USAMRIID shutdown on research at Fort Detrick unclear appeared first on Healthier Environment Living Program.